4:21PM Genomic Health beats by $0.03, beats on revs; guides FY13 EPS above consensus, revs in-line (GHDX) 28.63 +0.28 : Reports Q4 (Dec) earnings of $0.06 per share, $0.03 better than the Capital IQ Consensus Estimate of $0.03; revenues rose 13.1% year/year to $60.4 mln vs the $59.06 mln consensus.
Co issues mixed guidance for FY13, sees non-GAAP EPS of $0.48-0.68 vs. $0.28 Capital IQ Consensus Estimate, also reports GAAP est of ($0.12)-$0.08; sees FY13 revs of $258-266 mln vs. $263.90 mln Capital IQ Consensus Estimate.